Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex.

Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex.

Item
http://www.wikidata.org/entity/Q33710923
Physicochemical characterization, identification and improved photo-stability of α-lipoic acid-loaded nanostructured lipid carrier.Nanotechnology: a magic bullet for HIV AIDS treatment.Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy.Formulation, Characterisation, and in Vitro Skin Diffusion of Nanostructured Lipid Carriers for Deoxyarbutin Compared to a Nanoemulsion and Conventional Cream.Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect.Amino acid esters substituted phosphorylated emtricitabine and didanosine derivatives as antiviral and anticancer agents.Submicron-size biodegradable polymer-based didanosine particles for treating HIV at early stage: an in vitro study.Analysis of in vivo absorption of didanosine tablets in male adult dogs by HPLC.Doxorubicin and cisplatin loaded nanostructured lipid carriers for breast cancer combination chemotherapy.
P2860

Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex.

Item
http://www.wikidata.org/entity/Q33710923
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Formulation development and in ...... ment of AIDS dementia complex.
@ast
Formulation development and in ...... ment of AIDS dementia complex.
@en
type
label
Formulation development and in ...... ment of AIDS dementia complex.
@ast
Formulation development and in ...... ment of AIDS dementia complex.
@en
prefLabel
Formulation development and in ...... ment of AIDS dementia complex.
@ast
Formulation development and in ...... ment of AIDS dementia complex.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Formulation development and in ...... tment of AIDS dementia complex
@en
P2093
P2860
P304
P31
P356
10.3109/03639045.2010.516264
P407
P433
P478
P50
P577
P5875
P698